| Literature DB >> 28778704 |
Lorenzo Cavagna1, Sara Monti2, Roberto Caporali2, Mariele Gatto3, Luca Iaccarino3, Andrea Doria3.
Abstract
Management of patients with idiopathic inflammatory myopathies (IIMs) is challenging given the systemic nature of the disease, which is often complicated by potentially life-threatening manifestations and the lack of standardized treatment regimens. Aim of this review is to provide the currently available evidence for immunotherapy in the treatment of various manifestations of IIM in order to help clinicians in the daily management of these patients.Entities:
Keywords: Antisynthetase syndrome; Glucocorticoids; Idiopathic inflammatory myopathies; Immunosuppressants; Therapy
Mesh：
Year: 2017 PMID： 28778704 DOI： 10.1016/j.autrev.2017.07.016
Source DB: PubMed Journal: Autoimmun Rev ISSN： 1568-9972 Impact factor: 9.754